Labshares Newton Awards Free Project-Based Lab Space to Three Innovative Diagnostics Companies Conducting COVID-19 Research
Labshares News
Related or similar articles
May 6, 2025
How AI is Revolutionizing Biotech—and Why Labshares Remains the Ideal Home for Emerging Biotechs
AI is transforming biotech by accelerating drug discovery, diagnostics, and research. Emerging AI-biotech companies still need flexible wet lab space, advanced equipment, and experimental validation to bring discoveries to market.
Blog Posts
August 8, 2018
Harbour BioMed inks $350 million deal for rights to A167
USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
Member News
November 13, 2025
Labshares Expands to Watertown, Doubling Its Footprint and Bringing Its Shared Lab Model to More Biotechs
With occupancy nearing 90% across its existing facilities, Labshares is expanding to more than 100,000 square feet to meet demand for flexible, capital-efficient lab space that helps biotechs scale smarter and focus on science.
Press Releases